Nutrition
Volume 26, Issue 5 , Pages 482-490 , May 2010

Three targets of branched-chain amino acid supplementation in the treatment of liver disease

  • Milan Holecek, M.D.

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +420-495-816-335; fax: +420-495-816-335.

Received 10 March 2009 ,Accepted 24 June 2009.

References 

  1. Tischler ME, Desautels M, Goldberg AL. Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle?. J Biol Chem. 1982;257:1613–1621
  2. Kimball SR, Jefferson LS. Regulation of protein synthesis by branched-chain amino acids. Curr Opin Clin Nutr Metab Care. 2001;4:39–43
  3. Nair KS, Short KR. Hormonal and signaling role of branched-chain amino acids. J Nutr. 2005;135:1547S–1552S
  4. Golden MHN. Metabolism of branched chain amino acids. In:  Waterlow JC,  Stephen JM editor. Nitrogen metabolism in man. London: Applied Science; 1981;p. 109–110
  5. Lowenstein JM. Ammonia production in muscle and other tissues. The purine nucleotide cycle. Physiol Rev. 1972;52:382–414
  6. Harris RA, Joshi M, Jeoung NH. Mechanisms responsible for regulation of branched-chain amino acid catabolism. Biochem Biophys Res Commun. 2004;313:391–396
  7. Brosnan JT, Brosnan ME. Branched-chain amino acids: enzyme and substrate regulation. J Nutr. 2006;136:207S–211S
  8. Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism. Annu Rev Nutr. 1984;4:409–454
  9. Flores EA, Bistrian BR, Pomposelli JJ, Dinerallo CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. J Clin Invest. 1989;83:1614–1622
  10. Nawabi MD, Block KP, Chakrabarti MC, Buse MG. Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain α-keto acid dehydrogenase. J Clin Invest. 1990;85:256–263
  11. Holecek M, Sprongl L, Skopec F, Andrys C, Pecka M. Leucine metabolism in TNF-α- and endotoxin-treated rats: contribution of hepatic tissue. Am J Physiol Endocrinol Metab. 1997;273:E1052–E1058
  12. Cerra FB, Mazuski JE, Chute E, Nuwer N, Teasley K, Lysne J, et al. Branched chain metabolic support. A prospective, randomized, double-blind trial in surgical stress. Ann Surg. 1984;199:286–291
  13. Heyman MB. General and specialized parenteral amino acid formulations for nutrition support. J Am Diet Assoc. 1990;90:401–408
  14. Freund HR, Hanani M. The metabolic role of branched-chain amino acids. Nutrition. 2002;18:287–288
  15. De Bandt J-P, Cynober L. Therapeutic use of branched-chain amino acids in burn, trauma and sepsis. J Nutr. 2006;136:308S–313S
  16. Nishitani S, Takehana K. Pharmacological activities of branched-chain amino acids: augmentation of albumin synthesis in liver and improvement of glucose metabolism in skeletal muscle. Hepatol Res. 2004;30S:19–24
  17. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003;124:1792–1801
  18. Marchesini G, Marzocchi R, Noia M, Bianchi G. Branched-chain amino acid supplementation in patients with liver diseases. J Nutr. 2005;135:1596S–1601S
  19. Khanna S, Gopalan S. Role of branched-chain amino acids in liver disease: the evidence for and against. Curr Opin Clin Nutr Metab Care. 2007;10:297–303
  20. Nakaya Y, Okita K, Suzuki K, Moriwaki H, Kato A, Miwa Y, et al. Hepatic Nutritional Therapy (HNT) Study Group. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition. 2007;23:113–120
  21. O'Grady J. Attempting to predict the unpredictable in acute liver injury. J Hepatol. 2005;42:5–6
  22. Rosen HM, Yoshimura N, Hodgman JM, Fischer JE. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology. 1977;72:483–487
  23. Shi ZQ, Chang TMS. Amino acid disturbances in experimental hepatic coma rats. Int J Artif Org. 1984;7:197–202
  24. Hehir DJ, Jenkins RL, Bistrian BR, Wagner D, Moldawer LL, Young VR, et al. Abnormal phenylalanine hydroxylation and tyrosine oxidation in a patient with acute fulminant liver disease with correction by liver transplantation. Gastroenterology. 1985;89:659–663
  25. Holecek M, Mraz J, Tilser I. Plasma amino acids in four models of experimental liver injury in rats. Amino Acids. 1996;10:229–241
  26. Holecek M, Skalska H, Mraz J. Plasma amino acid levels after carbon tetrachloride induced acute liver damage. A dose–response and time–response study in rats. Amino Acids. 1999;16:1–11
  27. Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Williams R. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest. 1976;6:387–394
  28. Flock EV, Mann FC, Bollman JL. Free amino acids in plasma and muscle following total removal of the liver. J Biol Chem. 1951;192:293–300
  29. Iber FL, Rosen H, Levenson SM, Chalmers TC. The plasma amino acids in patients with liver failure. J Lab Clin Med. 1957;50:417–425
  30. Soeters PB, de Boer J. Why are plasma branched chain amino acid levels diminished in patients with liver cirrhosis?. In:  Adibi SA,  Fekl W,  Langenbeck U,  Schauder P editor. Branched chain amino and keto acids in health and disease. Basel: Karger; 1984;p. 483–496
  31. Marchesini G, Forlani G, Zoli M, Angiolini A, Scolari MP, Bianchi FB, et al. Insulin and glucagon levels in liver cirrhosis. Relationship with plasma amino acid imbalance of chronic hepatic encephalopathy. Dig Dis Sci. 1979;24:594–601
  32. Eriksson LS, Hagenfeldt L, Wahren J. Intravenous infusion of alpha-oxoisocaproate: influence on amino acid and nitrogen metabolism in patients with liver cirrhosis. Clin Sci (Lond). 1982;62:285–293
  33. Hayashi M, Ikezawa K, Ono A, Okabayashi S, Hayashi Y, Shimizu S, et al. Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis. Hepatol Res. 2007;37:615–619
  34. Yamato M, Muto Y, Yoshida T, Kato M, Moriwaki H. Clearance rate of plasma branched-chain amino acids correlates significantly with blood ammonia level in patients with liver cirrhosis. Int Hepatol Commun. 1995;3:91–96
  35. Leweling H, Breitkreutz R, Behne F, Staedt U, Striebel JP, Holm E. Hyperammonemia-induced depletion of glutamate and branched-chain amino acids in muscle and plasma. J Hepatol. 1996;25:756–762
  36. Holecek M, Sprongl L, Tichy M. Effect of hyperammonemia on leucine and protein metabolism in rats. Metabolism. 2000;49:1330–1334
  37. Bessman SP, Bessman AN. The cerebral and peripheral uptake of ammonia in liver disease with a hypothesis for the mechanism of hepatic coma. J Clin Invest. 1955;34:622–628
  38. Butterworth RF. Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci. 1992;37:321–327
  39. James JH. Branched chain amino acids in hepatic encephalopathy. Am J Surg. 2002;183:424–429
  40. Bachmann C. Mechanisms of hyperammonemia. Clin Chem Lab Med. 2002;40:653–662
  41. Albrecht J, Sonnewald U, Waagepetersen HS, Schousboe A. Glutamine in the central nervous system: function and dysfunction. Front Biosci. 2007;12:332–343
  42. Llansola M, Rodrigo R, Monfort P, Montoliu C, Kosenko E, Cauli O, et al. NMDA receptors in hyperammonemia and hepatic encephalopathy. Metab Brain Dis. 2007;22:321–335
  43. Rodrigo R, Cauli O, Boix J, El Mlili N, Agusti A, Felipo V. Role of NMDA receptors in acute liver failure and ammonia toxicity: therapeutical implications. Neurochem Int. 2009;55:113–118
  44. Hermenegildo C, Montoliu C, Llansola M, Muñoz MD, Gaztelu JM, Miñana MD, et al. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur J Neurosci. 1998;10:3201–3209
  45. Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet. 1971;ii:75–80
  46. Fischer JE, Funovics J, Aguirre A, James JH, Keane JM, Wesdorp RI, et al. The role of plasma amino acids in hepatic encephalopathy. Surgery. 1975;78:276–290
  47. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery. 1976;80:77–91
  48. Fischer JE. Branched-chain–enriched amino acid solutions in patients with liver failure: an early example of nutritional pharmacology. JPEN. 1990;14(suppl):249S–256S
  49. Rössle M, Luft M, Herz R, Klein B, Lehmann M, Gerok W. Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution. Klin Wochenschr. 1984;62:867–875
  50. Bombardieri G, Gigli GL, Bernardi L, Ferri R, Grassi C, Milani A. Visual evoked potential recordings in hepatic encephalopathy and their variations during branched chain amino-acid treatment. Hepatogastroenterology. 1985;32:3–7
  51. Rossi Fanelli F, Cangiano C, Capocaccia L, Cascino A, Ceci F, Muscaritoli M, et al. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences. Gut. 1986;27(suppl 1):111–115
  52. Plauth M, Egberts EH, Hamster W, Török M, Müller PH, Brand O, et al. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. J Hepatol. 1993;17:308–314
  53. Wahren J, Denis J, Desurmont P, Eriksson LS, Escoffier JM, Gauthier AP, et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology. 1983;3:475–480
  54. Kanematsu T, Koyanagi N, Matsumata T, Kitano S, Takenaka K, Sugimachi K. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial. Surgery. 1988;104:482–488
  55. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev. 2003;2:CD001939
  56. MacLean DA, Graham TE, Saltin B. Stimulation of muscle ammonia production during exercise following branched-chain amino acid supplementation in humans. J Physiol. 1996;493:909–922
  57. Caraceni P, Nardo B, Domenicali M, Turi P, Vici M, Simoncini M, et al. Ischemia–reperfusion injury in rat fatty liver: role of nutritional status. Hepatology. 1999;29:1139–1146
  58. Nygren J, Thorell A, Ljungqvist O. Preoperative oral carbohydrate nutrition: an update. Curr Opin Clin Nutr Metab Care. 2001;4:255–259
  59. Hassanain M, Schricker T, Metrakos P, Carvalho G, Vrochides D, Lattermann R. Hepatic protection by perioperative metabolic support?. Nutrition. 2008;24:1217–1219
  60. Holecek M, Simek J. Different effects of glucose and intralipid on the onset of liver regeneration in the early period after partial hepatectomy in the rat. Exp Pathol. 1988;33:257–260
  61. Chanda S, Mehendale HH. Nutritional impact on the final outcome of liver injury inflicted by model hepatotoxicants: effect of glucose loading. FASEB J. 1995;9:240–245
  62. Holecek M. Nutritional modulation of liver regeneration by carbohydrates, lipids, and amino acids: a review. Nutrition. 1999;15:784–788
  63. Ngala-Kenda JF, De Hemptine B, Lambotte L. Role of metabolic overload in the inhibition of DNA synthesis following partial hepatectomy in the rats. Eur Surg Res. 1984;16:294–302
  64. Holecek M, Simek J, Zadak Z, Blaha V. Acceleration of the onset of liver regeneration by carnitine in partially hepatectomized rats. Physiol Bohemoslov. 1989;38:503–508
  65. Holecek M, Mraz J, Koldova P, Skopec F. Effect of polyunsaturated phosphatidylcholine on liver regeneration onset after hepatectomy in the rat. Arzneim Forsch Drug Res. 1992;42:337–339
  66. Jenkins PJ, Portmann BP, Eddleston ALWF, Williams R. Use of polyunsaturated phosphatidyl choline in HBsAg negative chronic active hepatitis: results of prospective double-blind controlled trial. Liver. 1982;2:77–81
  67. Müller MJ, Rieger A, Willmann O, Lautz HU, Balks HJ, Von Zur Mühlen A, et al. Metabolic responses to lipid infusions in patients with liver cirrhosis. Clin Nutr. 1992;11:193–206
  68. Nagayama M, Takai T, Okuno M, Umeyama K. Fat emulsion in surgical patients with liver disorders. J Surg Res. 1989;47:59–64
  69. Holecek M, Simek J, Kruf M, Zadak Z. Effect of branched-chain amino acids on liver regeneration after partial hepatectomy. Physiol Bohemoslov. 1985;34:359–366
  70. Rigotti P, Peters JC, Tranberg KO, Fuscher JE. Effect of amino acid infusion on liver regeneration after partial hepatectomy in the rat. JPEN. 1986;10:17–20
  71. Holecek M, Simek J, Palicka V, Zadak Z. Effect of glucose and branched chain amino acids (BCAA) infusion on onset of liver regeneration and plasma amino acid pattern in partially hepatectomized rat. J Hepatol. 1991;13:14–20
  72. Meng WC, Leung KL, Ho RL, Leung TW, Lau WY. Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma. Aust N Z J Surg. 1999;69:811–815
  73. Togo S, Tanaka K, Morioka D, Sugita M, Ueda M, Miura Y, et al. Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis. Nutrition. 2005;21:480–486
  74. The San-in Group of Liver Surgery. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. Br J Surg. 1997;84:1525–1531
  75. Bucher NLR, Swaffield MN. Synergistic action of glucagon and insulin in regulation of hepatic regeneration. Adv Enzyme Regul. 1975;13:281–293
  76. Tomiya T, Inoue Y, Yanase M, Arai M, Ikeda H, Tejima K, et al. Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochem Biophys Res Commun. 2002;297:1108–1111
  77. Yoshida S, Yunoki T, Aoyagi K, Ohta J, Ishibashi N, Noake T, et al. Effect of glutamine supplement and hepatectomy on DNA and protein synthesis in the remnant liver. J Surg Res. 1995;59:475–481
  78. Ito A, Higashiguchi T. Effects of glutamine administration on liver regeneration following hepatectomy. Nutrition. 1999;15:23–28
  79. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793–799
  80. Morgan MY. Alcohol and nutrition. Br Med Bull. 1982;38:21–29
  81. Charlton M. Branched-chain amino acid enriched supplements as therapy for liver disease. J Nutr. 2006;136:295S–298S
  82. Peng S, Plank LD, McCall JL, Gillanders LK, McIlroy K, Gane EJ. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr. 2007;85:1257–1266
  83. Petrides AS, Schulze-Berge D, Vogt C, Matthews DE, Strohmeyer G. Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology. 1993;18:284–291
  84. Kato M, Miwa Y, Tajika M, Hiraoka T, Muto Y, Moriwaki H. Preferential use of branched-chain amino acids as an energy substrate in patients with liver cirrhosis. Intern Med. 1998;37:429–434
  85. Holecek M, Tilser I, Skopec F, Sprongl L. Leucine metabolism in cirrhotic rats. J Hepatol. 1996;24:209–216
  86. O'Keefe S, Abraham R, Davis M, Williams R. Protein turnover in acute and chronic liver disease. Acta Chir Scand. 1980;507:91–100
  87. Blonde-Cynober F, Plassart F, Rey C, Coudray-Lucas C, Moukarbel N, Poupon R, et al. Assessment of the carbon tetrachloride-induced cirrhosis model for studies of nitrogen metabolism in chronic liver disease. Ann Nutr Metab. 1994;38:238–248
  88. Swart GR, van den Berg JWQ, Wattimena JLD, Rietveld T, van Vuure JK, Frenkel M. Elevated protein requirements in cirrhosis of the liver investigated by whole-body protein turnover studies. Clin Sci. 1988;75:101–107
  89. Holdsworth JD, Dionigi P, Clague MB, James OFW, Wright PD. Body protein metabolism and plasma amino acids in cirrhosis of the liver. The effect of varying the branched chain amino acid content of intravenous amino acid solutions. Clin Nutr. 1984;3:153–162
  90. Millikan WJ, Henderson JM, Galloway JR, Warren WD, Matthews DE, McGhee A, et al. In vivo measurement of leucine metabolism with stable isotopes in normal subjects and in those with cirrhosis fed conventionally? And branched-chain amino acid–enriched diets. Surgery. 1985;98:405–412
  91. Mullen KD, Denne SC, McCullough AJ, Savin SM, Bruno D, Tavil AS, et al. Leucine metabolism in stable cirrhosis. Hepatology. 1986;6:622–663
  92. Merli M, Riggio O, Romiti A, Ariosto F, Mango L, Pinto G, et al. Basal energy production rate and substrate use in stable cirrhotic patients. Hepatology. 1990;12:106–112
  93. Schott K, Poetter U, Neuhoff V. Ammonia inhibits protein synthesis in slices from young rat brain. J Neurochem. 1984;42:644–646
  94. Hopgood MF, Clark MG, Ballard FJ. Inhibition of protein degradation in isolated hepatocytes. Biochem J. 1977;164:399–407
  95. Kadowaki M, Kanazawa T. Amino acids as regulators of proteolysis. J Nutr. 2003;133:2052S–2056S
  96. Schutz T, Zillich DP, Jurczyk S, Ertel S, Lochs H, Plauth M. Improvement in body composition after transjugular intrahepatic portosystemic stent-shunt (TIPS) in patients with cirrhosis. Gastroenterology. 1999;116:A1274
  97. Holecek M, Skopec F, Sprongl L. Protein metabolism in cirrhotic rats: effect of dietary restriction. Ann Nutr Metab. 1995;39:346–354
  98. Holecek M, Skopec F, Skalska H, Sprongl L. Effect of alanyl-glutamine on leucine and protein metabolism in endotoxemic rats. JPEN. 2000;24:215–222
  99. Holecek M. Relation between glutamine, branched-chain amino acids, and protein metabolism. Nutrition. 2002;18:130–133
  100. Thomsen KL, Nielsen SS, Gronbiek H, Flyvberg A, Vilstrup H. Effects of lipopolysaccharide endotoxin on the insulin-like growth factor I system in rats with cirrhosis. Vivo. 2008;22:655–661
  101. Watanabe A, Wakabayashi H, Kuwabara Y. Nutrient-induced thermogenesis and protein-sparing effect by rapid infusion of a branched chain–enriched amino acid solution to cirrhotic patients. J Med. 1996;27:176–182
  102. Lang CH, Frost RA. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle. J Cell Physiol. 2005;203:144–155
  103. Garlick PJ. The role of leucine in the regulation of protein metabolism. J Nutr. 2005;135:1553S–1556S
  104. Kawaguchi T, Nagao Y, Matsuoka H, Ide T, Sata M. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Int J Mol Med. 2008;22:105–112
  105. Chua B, Siehl DL, Morgan HE. Effect of leucine and metabolites of branched chain amino acids on protein turnover in heart. J Biol Chem. 1979;254:8358–8362
  106. Holecek M, Muthny T, Kovarik M, Sispera L. Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues. Food Chem Toxicol. 2009;47:255–259
  107. Shirabe K, Matsumata T, Shimada M, Takenaka K, Kawahara N, Yamamoto K, et al. A comparison of parenteral hyperalimentation and early enteral feeding regarding systemic immunity after major hepatic resection—the results of a randomized prospective study. Hepatogastroenterology. 1997;44:205–209
  108. Mukai J, Tokuyama E, Ishizaka T, Okada S, Uchida T. Inhibitory effect of aroma on the bitterness of branched-chain amino acid solutions. Chem Pharm Bull (Tokyo). 2007;55:1581–1584
  109. Malaguarnera M, Risino C, Cammalleri L, Malaguarnera L, Astuto M, Vecchio I, et al. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study. Eur J Gastroenterol Hepatol. 2009;21:762–770
  110. Hayashi M, Ohnishi H, Kawade Y, Muto Y, Takahashi Y. Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication. Gastroenterol Jpn. 1981;16:64–70

 This work was supported by Research Project MSM 0021620820.

PII: S0899-9007(09)00308-6

doi: 10.1016/j.nut.2009.06.027

Nutrition
Volume 26, Issue 5 , Pages 482-490 , May 2010

Article Tools

* Image Usage & Resolution